In a filing, Travere Therapeutics Inc revealed its Officer Peter Heerma acquired Company’s shares for reported $0.1 million on Feb
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Travere Therapeutics Inc’s recently made public that its SENIOR VICE PRESIDENT, R&D ROTE WILLIAM E. unloaded Company’s shares for reported
Travere Therapeutics Inc’s filing revealed that its CHIEF MEDICAL OFFICER Inrig Jula unloaded Company’s shares for reported $39461.0 on Jan
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Travere Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Inrig Jula unloaded Company’s shares for reported $39461.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Travere Therapeutics Inc’s recent filing unveils that its SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra unloaded Company’s shares for reported $0.26
